NO992724L - Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives - Google Patents

Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives

Info

Publication number
NO992724L
NO992724L NO992724A NO992724A NO992724L NO 992724 L NO992724 L NO 992724L NO 992724 A NO992724 A NO 992724A NO 992724 A NO992724 A NO 992724A NO 992724 L NO992724 L NO 992724L
Authority
NO
Norway
Prior art keywords
amphiphilic
sulfonyl
mixtures containing
surfactant
indoline derivatives
Prior art date
Application number
NO992724A
Other languages
Norwegian (no)
Other versions
NO992724D0 (en
Inventor
Jean-Claude Gautier
Simon John Fuller
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO992724L publication Critical patent/NO992724L/en
Publication of NO992724D0 publication Critical patent/NO992724D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår et vannfritt solubiliserings/stabiliserings- system som er emulgerbart eller mikroemulgerbart i vann, for solubiliseringen av hydrofobe derivater av N-sulfonylindolin med formel: OCH kjennetegnet ved at det omfatter en eller flere bestanddeler valgt fra amfifile for- bindelser, ikke-ioniske, hydrofile, overflateaktive midler og ikke-ioniske, hydrofile forbindelser utstyrt med både amfifile og overflateaktive egenskaper, idet det skal forstås at det nevnte system omfatter enten minst en blanding av en amfifil forbin- delse og av et ikke-ionisk, hydrofilt, overflateaktivt middel eller minst en ikke- ionisk, hydrofil forbindelse utstyrt med både overflateaktive og amfifile egenskaper.The present invention relates to an anhydrous solubilization / stabilization system which is emulsifiable or microemulsifiable in water, for the solubilization of hydrophobic derivatives of N-sulfonylindoline of formula: AND characterized by comprising one or more constituents selected from amphiphilic compounds, nonionic hydrophilic surfactants and nonionic hydrophilic compounds having both amphiphilic and surfactant properties, it being understood that said system comprises either at least one mixture of an amphiphilic compound and of a nonionic hydrophilic surfactant. or at least a nonionic, hydrophilic compound equipped with both surfactant and amphiphilic properties.

NO992724A 1996-12-05 1999-06-04 Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives NO992724D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (en) 1996-12-05 1996-12-05 PHARMACEUTICAL COMPOSITIONS CONTAINING N-SULFONYL INDOLINE DERIVATIVES
PCT/FR1997/002210 WO1998024430A1 (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonyl indolin derivatives

Publications (2)

Publication Number Publication Date
NO992724L true NO992724L (en) 1999-06-04
NO992724D0 NO992724D0 (en) 1999-06-04

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992724A NO992724D0 (en) 1996-12-05 1999-06-04 Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives

Country Status (25)

Country Link
EP (1) EP0941090A1 (en)
JP (1) JP2000507618A (en)
KR (1) KR20000069308A (en)
CN (1) CN1239887A (en)
AR (1) AR009651A1 (en)
AU (1) AU716575B2 (en)
BR (1) BR9712406A (en)
CA (1) CA2273990A1 (en)
CO (1) CO4910129A1 (en)
DZ (1) DZ2362A1 (en)
EE (1) EE9900206A (en)
FR (1) FR2756736B1 (en)
HU (1) HUP0001386A3 (en)
ID (1) ID23373A (en)
IL (1) IL129936A0 (en)
IS (1) IS5062A (en)
MY (1) MY132819A (en)
NO (1) NO992724D0 (en)
NZ (1) NZ335750A (en)
RU (1) RU2174394C2 (en)
SK (1) SK75599A3 (en)
TR (1) TR199901702T2 (en)
WO (1) WO1998024430A1 (en)
YU (1) YU23099A (en)
ZA (1) ZA9710919B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (en) * 1998-11-16 2000-12-08 Sanofi Sa PROCESS FOR THE PREPARATION OF (2S) -1 - [(2R, 3S) -5-CHLORO-3- (2- CHLOROPHENYL) -1- (3,4-DIMETHOXY BENZENESULFONYL) -3-HYDROXY- 2,3-DIHYDRO- 1H-INDOLE-2-CARBONYL] PYRROLIDINE-2-CARBOXAMIDE, ITS SOLVATES AND / OR HYDRATES
DE19913692A1 (en) * 1999-03-25 2000-09-28 Basf Ag Mechanically stable pharmaceutical dosage forms containing liquid or semi-solid surface-active substances
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
JP5767429B2 (en) 1999-11-12 2015-08-19 アッヴィ・インコーポレイテッド Crystallization inhibitors in solid dispersants
FR2805992A1 (en) * 2000-03-08 2001-09-14 Sanofi Synthelabo Oral administration of N-sulfonyl-indoline derivative to treat central nervous system, cardiovascular or gastric disorders, using polyethylene glycol, polysorbate and poloxamer as solubilizers for high bioavailability
DE10026698A1 (en) 2000-05-30 2001-12-06 Basf Ag Self-emulsifying active ingredient formulation and use of this formulation
ITMI20011338A1 (en) 2001-06-26 2002-12-26 Farmatron Ltd ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (en) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
KR102139339B1 (en) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 Cosmetic composition which has improved solubility comprising indole compound
KR102139338B1 (en) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 Cosmetic composition which has improved solubility comprising indole compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (en) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. WATER-FREE EMULSIONS AND USE THEREOF
FR2679903B1 (en) * 1991-08-02 1993-12-03 Elf Sanofi DERIVATIVES OF N-SULFONYL INDOLINE CARRYING AN AMIDIC FUNCTION, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.

Also Published As

Publication number Publication date
BR9712406A (en) 1999-08-31
WO1998024430A1 (en) 1998-06-11
EE9900206A (en) 1999-12-15
FR2756736B1 (en) 1999-03-05
YU23099A (en) 1999-11-22
SK75599A3 (en) 2000-08-14
TR199901702T2 (en) 1999-09-21
RU2174394C2 (en) 2001-10-10
NO992724D0 (en) 1999-06-04
HUP0001386A2 (en) 2001-04-28
CO4910129A1 (en) 2000-04-24
EP0941090A1 (en) 1999-09-15
AU5326298A (en) 1998-06-29
ZA9710919B (en) 1999-06-04
ID23373A (en) 2000-04-20
FR2756736A1 (en) 1998-06-12
DZ2362A1 (en) 2002-12-28
AR009651A1 (en) 2000-04-26
CA2273990A1 (en) 1998-06-11
CN1239887A (en) 1999-12-29
IL129936A0 (en) 2000-02-29
JP2000507618A (en) 2000-06-20
HUP0001386A3 (en) 2002-03-28
MY132819A (en) 2007-10-31
IS5062A (en) 1999-06-01
AU716575B2 (en) 2000-03-02
NZ335750A (en) 2001-06-29
KR20000069308A (en) 2000-11-25

Similar Documents

Publication Publication Date Title
NO992724L (en) Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives
NO964813D0 (en) Method for Stabilization of Duocarmycin Derivatives
FI962494A0 (en) 5- (2-imidazolinylamino) benzimidazole derivatives, their preparation and their use as alpha-2-adrenoceptor agonists
DK0679157T3 (en) Novel 3,4-diarylthiophenes and analogs thereof for use as anti-inflammatory agents
WO2001056989A3 (en) Inhibitors of factor xa
DE69025336D1 (en) Antihypertensive preparations and their use
AU698744B2 (en) Oil-in-water emulsions
DK0669935T3 (en) Compounds useful as sweeteners and processes for their preparation
AU7524591A (en) Nematicidal compositions
PE20001225A1 (en) DERIVATIVES OF ADENINE
WO1999063826A3 (en) Agents for combating plant pests
CA2221114A1 (en) Atherosclerosis treatment
AR012156A1 (en) NEUROMUSCULAR BLOCKERS DERIVED FROM ISOQUINOLINIO OF ULTRA SHORT ACTION, COMPOSITION CONTAINING THEM, USE OF SUCH COMPOUND, INTERMEDIARIES AND PROCESS FOR ITS PREPARATION.
WO2001072708A3 (en) OXINDOLE INHIBITORS OF FACTOR Xa
NO933611L (en) ANTI-TUMOR AND ANTI-PSORIATIC AGENTS
NO971789L (en) Di-tert-butylphenol compounds with heterocyclic moiety for use as anti-inflammatory agents
CA2316082A1 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
DE3364588D1 (en) Fungicidal agent
AU2002340578A1 (en) Compounds for use as surfactants
NO951811L (en) Quinoline and benzimidazole derivatives, their preparation and use
BR9908796A (en) Use of macrolide compounds, method of treatment and prevention of ards, pharmaceutical composition and macrolide compound
WO2002026731A3 (en) Quaternary amidino based inhibitors of factor xa
ES2077867T3 (en) 3-CARBAMOIL-4-HYDROXICUMARINES ANTIHELMINTICAS AND ANTICOCCIDIALES, PROCEDURE FOR USE AND COMPOSITIONS.
HK1040710A1 (en) Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
GB2276619A (en) Cyclic ketal derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application